US4073723A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Anti-coagulating and filtering blood
Assignee: Terumo BCT Inc
•
Filing: 1976-11-15
•
Granted: 1978-02-14
•
Expires: 1996-11-15
Abstract
Abstract Blood is passed through a heparin coated mass of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton or cellulose. Thereafter the blood is passed through a mass of the same filamentous material which is not heparin coated, for removal of its content of leucocytes and platelets preliminary to blood bank storage and/or use in transfusions. Passage of the blood through the heparin-coated filamentous resin in the first step prevents the blood from coagulating in the second step. The apparatus employed for the treatment comprises a vessel having an inlet with means for connection to a source of untreated blood; an outlet with means for connection to a receiving vessel; and a packing comprising at least one filamentous material of the group listed above. The packing comprises an upstream portion comprising heparinized filamentous material and a downstream portion comprising filamentous packing material substantially free from heparin. The upstream heparinized portion prevents the blood from coagulating while passing through the downstream unheparinized packing portion which thereupon removes the leucocytes and platelets from the blood.
Inventors
- 👤 Roy L. Swank
- 👤 David Danon
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 15:52
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3672; A61M1/3673; A61M1/3679
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
135 words
The method of treating blood which comprises (a) soaking in an aqueous solution of heparin at least one filamentous material of the class consisting of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton and cellulose, (b) draining the excess heparin solution from the filamentous material, (c) drying the filamentous material, whereby the dry heparin forms a coating on the surface of the filamentous material, (d) the heparin concentration of the aqueous solution and the soaking time of the filamentous material therein being chosen so that the amount of dry heparin coating is from about 0.00025 to about 0.0025 percent, dry weight basis, (e) and thereafter passing blood through a fluffed mass of a blood anti-coagulating quantity of said heparin-coated filamentous material at a rate to effect anti-coagulation of substantially all of said blood.
Claim 2
Independent Claim
135 words
The method of treating blood which comprises (a) soaking in an aqueous solution of heparin at least one filamentous material of the class consisting of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton and cellulose, (b) draining the excess heparin solution from the filamentous material, (c) drying the filamentous material, whereby the dry heparin forms a coating on the surface of the filamentous material, (d) the heparin concentration of the aqueous solution and the soaking time of the filamentous material therein being chosen so that the amount of dry heparin coating is from about 0.00025 to about 0.0025 percent, dry weight basis, (e) and thereafter passing blood through a fluffed mass of a blood anti-coagulating quantity of said heparin-coated filamentous material at a rate to effect anti-coagulation of substantially all of said blood.
Claim 3
Dependent Claim
42 words
The method of claim 1 wherein the aqueous solution of heparin contains from 0.02 to 0.2% by weight heparin, and the soaking time is from about 5 to about 15 minutes, and including the step of air drying the heparin-treated filamentous material.
Claim 4
Dependent Claim
41 words
The method of claim 1 followed by the step of passing the anti-coagulated blood through at least one of the said filamentous materials in a heparin-lean condition for removing from the blood a substantial proportion of its leucocyte and platelet content.
Claim 5
Dependent Claim
12 words
The method of claim 3 wherein the filamentous material comprises polyester resin.
Claim 6
Dependent Claim
12 words
The method of claim 3 wherein the filamentous material comprises polyamide resin.
Claim 7
Dependent Claim
12 words
The method of claim 3 wherein the filamentous material comprises polyacrylic resin.
Claim 8
Dependent Claim
11 words
The method of claim 3 wherein the filamentous material comprises glass.
Claim 9
Dependent Claim
11 words
The method of claim 3 wherein the filamentous material comprises cotton.
Claim 10
Dependent Claim
22 words
The method of claim 3 wherein the filamentous material is comprised of filaments having average diameters of less than about 60 microns.
Claim 11
Dependent Claim
22 words
The method of claim 3 wherein the filamentous material is comprised of filaments having average diameters of less than about 30 microns.
Claim 12
Dependent Claim
23 words
The method of claim 3 including the step of mixing with the treated blood a blood bank storage quantity of anti-coagulant acid-citrate-dextrose solution.
Claim 13
Dependent Claim
23 words
The method of claim 3 including the step of mixing with the treated blood a blood bank storage quantity of anti-coagulant citrate-phosphate-dextrose solution.
Claim 14
Dependent Claim
59 words
The method of claim 3 wherein the filamentous material is coated with heparin by soaking it in an aqueous solution of heparin containing from about 0.02 to about 0.2% by weight heparin; and the heparin-coated filamentous material comprises from about 10 to about 35% by weight of the total quantity of filamentous material through which the blood is passed.
Claim 15
Dependent Claim
82 words
Apparatus for treating blood which comprises a vessel having an inlet with means for connecting to a source of blood to be treated, an outlet for evacuating treated blood, and a packing comprising a fluffed mass of at least one filamentous material of the class consisting of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton and cellulose coated with from about 0.00025 to about 0.0025 percent by weight heparin, based on the air dry weight of the coated filamentous material.
Claim 16
Dependent Claim
82 words
Apparatus for treating blood which comprises a vessel having an inlet with means for connecting to a source of blood to be treated, an outlet for evacuating treated blood, and a packing comprising a fluffed mass of at least one filamentous material of the class consisting of filamentous polyester resin, polyamide resin, polyacrylic resin, glass, steel, cotton and cellulose coated with from about 0.00025 to about 0.0025 percent by weight heparin, based on the air dry weight of the coated filamentous material.
Claim 17
Dependent Claim
29 words
The apparatus of claim 14 including downstream from the filamentous material a further quantity of at least one of said filamentous materials in a condition substantially free of heparin.
Claim 18
Dependent Claim
12 words
The apparatus of claim 15 wherein the filamentous material comprises polyester resin.
Claim 19
Dependent Claim
12 words
The apparatus of claim 15 wherein the filamentous material comprises polyamide resin.
Claim 20
Dependent Claim
12 words
The apparatus of claim 15 wherein the filamentous material comprises polyacrylic resin.
Claim 21
Dependent Claim
11 words
The apparatus of claim 15 wherein the filamentous material comprises glass.
Claim 22
Dependent Claim
11 words
The apparatus of claim 15 wherein the filamentous material comprises cotton.
Claim 23
Dependent Claim
21 words
The apparatus of claim 15 wherein the filamentous material is comprised of filaments having average diameters of less than 60 microns.
Claim 24
Dependent Claim
21 words
The apparatus of claim 15 wherein the filamentous material is comprised of filaments having average diameters of less than 30 microns.
Claim 25
Dependent Claim
28 words
The apparatus of claim 15 wherein the downstream heparin-free filamentous material comprises a quantity equal to from 90 to 75% by weight of the upstream heparinized filamentous material.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-02-13 | 1981-08-15 | 1982-02-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-02-13 | 1985-08-15 | 1986-02-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-02-13 | 1989-08-15 | 1990-02-14 | $7700.00 | Window Closed / Lapsed |